These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30059640)

  • 21. Does baseline hematocrit influence the assays of on-treatment platelet reactivity to clopidogrel?
    Pendyala LK; Loh JP; Lhermusier T; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Am Heart J; 2014 Oct; 168(4):545-51. PubMed ID: 25262265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading.
    Kim IS; Jeong YH; Tantry US; Park Y; Lee DH; Bliden KP; Koh JS; Park JR; Jang JS; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S; Gurbel PA
    Am Heart J; 2013 Jul; 166(1):95-103. PubMed ID: 23816027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
    Sibbing D; Braun S; Jawansky S; Vogt W; Mehilli J; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2008 Jan; 99(1):121-6. PubMed ID: 18217143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Sartori C; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Platelets; 2016 Sep; 27(6):576-82. PubMed ID: 27540959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cigarette smoking is associated with a dose-response effect in clopidogrel-treated patients with diabetes mellitus and coronary artery disease: results of a pharmacodynamic study.
    Ueno M; Ferreiro JL; Desai B; Tomasello SD; Tello-Montoliu A; Capodanno D; Capranzano P; Kodali M; Dharmashankar K; Charlton RK; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2012 Mar; 5(3):293-300. PubMed ID: 22440495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring ASA and P2Y12-specific platelet inhibition--comparison of conventional (single) and multiple electrode aggregometry.
    Krüger JC; Meves SH; Kara K; Mügge A; Neubauer H
    Scand J Clin Lab Invest; 2014 Oct; 74(7):568-74. PubMed ID: 25296945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays.
    Danielak D; Komosa A; Tomczak A; Graczyk-Szuster A; Lesiak M; Główka F; Karaźniewicz-Łada M
    Scand J Clin Lab Invest; 2017 May; 77(3):190-198. PubMed ID: 28276728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis.
    Liu Z; Xiang Q; Mu G; Xie Q; Zhou S; Wang Z; Chen S; Hu K; Gong Y; Jiang J; Cui Y
    Platelets; 2020; 31(1):3-14. PubMed ID: 30744477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.
    Tello-Montoliu A; Rivera J; Hernández-Romero D; Silvente A; Jover E; Quintana M; Orenes-Piñero E; Hurtado J; Ferreiro JL; Marín F; Valdés M
    Platelets; 2016 Dec; 27(8):777-783. PubMed ID: 27257022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of clinical characteristics, laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests.
    Elsenberg EH; van Werkum JW; van de Wal RM; Zomer AC; Bouman HJ; Verheugt FW; Berg JM; Hackeng CM
    Thromb Haemost; 2009 Oct; 102(4):719-27. PubMed ID: 19806258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA
    Thromb Haemost; 2014 Dec; 112(6):1198-208. PubMed ID: 25182660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease.
    Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
    Platelets; 2015; 26(6):545-51. PubMed ID: 25167467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head to Head Comparison of Two Point-of-care Platelet Function Tests Used for Assessment of On-clopidogrel Platelet Reactivity in Chinese Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    Yao Y; Zhang JH; Tang XF; He C; Ma YL; Xu JJ; Song Y; Liu R; Meng XM; Song L; Wang M; Gao RL; Yuan JQ
    Chin Med J (Engl); 2016 Oct; 129(19):2269-74. PubMed ID: 27647183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
    Ther Drug Monit; 2011 Feb; 33(1):94-8. PubMed ID: 21192314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of renal function on platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention with stenting.
    Breet NJ; de Jong C; Bos WJ; van Werkum JW; Bouman HJ; Kelder JC; Bergmeijer TO; Zijlstra F; Hackeng CM; Ten Berg JM
    Thromb Haemost; 2014 Dec; 112(6):1174-81. PubMed ID: 25231776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
    Cardiovasc Drugs Ther; 2015; 29(5):443-50. PubMed ID: 26428927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the platelet count drop method for assessment of platelet function in comparison with "gold standard" light transmission aggregometry.
    Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
    Thromb Res; 2009 Sep; 124(4):418-22. PubMed ID: 19250657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time from blood draw to multiple electrode aggregometry and association with platelet reactivity.
    Hesselbarth D; Gjermeni D; Szabo S; Siegel PM; Diehl P; Moser M; Bode C; Olivier CB
    J Thromb Thrombolysis; 2023 Jan; 55(1):134-140. PubMed ID: 36344849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; Luca GD;
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):143-50. PubMed ID: 26868495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.